Solutions

R&D Excellence

While life sciences innovation has delivered significant improvement in patient outcomes, the costs and time to develop new products continues to rise while the commercial success of these products has become more elusive.  R&D organizations need to become more cost effective in how they develop new products while also increasing the value of these products through stronger evidence, especially in the real world.

New (Real World) Evidence is Required

The evidence now required to support a pharmaceutical brand is becoming far more complex. Because pharmaceutical companies need to further prove to payers, physicians, and patients the value of their therapies, they need to create a more comprehensive strategy for developing evidence throughout the lifecycle of the brand, not just during clinical trials, but in the real world as well.

Clinical Trials are Expensive

About 80% of clinical trials either fail to meet or miss their milestones, while the complexity of trials continues to increase. The net result is an ever-increasing cost of development, with an average of $2-plus billion spent on the development cost of each asset. Trying to ensure that trials are operational and efficient in execution is essential to controlling costs, while also making sure new therapies are commercialized sooner.

Investment in New Technology and Analytics is Unrealized

While companies are investing in technology and analytics, these investments haven’t always produced the results expected – requiring pharmaceutical companies to look for new ways to improve the impact of this technology and new data in driving efficiency and value.

Pick Up the Pace on Patient Centricity

> READ ARTICLE

Four Pillars to Achieve Patient Centricity

> READ ARTICLE

Bringing business impact to the science of R&D

Lifecycle Evidence Strategy

Based on a deep understanding of payers, physicians, and patients, ZS helps clients generate the evidence required to articulate and support product value to various stakeholders. This includes the design of clinical trials, but also generating real-world evidence continuously throughout its lifecycle to demonstrate the effectiveness and value of the drug.

Clinical Trial Analytics

ZS brings cross-functional stakeholders together to focus on analytics which will reduce costs, risks and time associated with clinical trial design, planning and execution.  ZS helps clients optimize the feasibility of trials, assess site readiness, predict key drivers of site success, forecast patient enrollment and improve the likelihood that the trial will deliver the required evidence at the lowest cost.

Medical Affairs

ZS draws on proven methodologies, frameworks and deep analytics to design strategies and processes to improve resource planning, tackle tough departmental issues, and introduce new feedback mechanisms and KPIs that drive growth in the medical affairs space. In addition to assessing the internal needs across stakeholders within medical affairs, commercial, development, compliance and HR departments, ZS also leverages voice of the customer market research to gather feedback from customers about their own needs and MSLs’ effectiveness.

Clinical & Real-World Data Science

ZS helps companies use real-world data in a way that’s meaningful, scalable and actionable. By bringing together structured and unstructured data from across both primary sources (e.g., case report forms, electronic medical and health records, observational studies, patient registries and health surveys) and secondary sources (e.g., clinical chart reviews, registries, insurance claims databases, etc.), ZS can easily integrate and analyze the information to generate meaningful insights that improve the design and execution of studies and prove the value of their therapies.

R&D Intelligence Platforms

ZS eliminates the need for organizations to build the infrastructure to collect, standardize, analyze and visualize data. Bringing together technology and analytic capabilities, ZS helps to maximize the value of the real world evidence and optimize the execution of clinical trials – allowing you to increase business impact at a lower investment cost.

Pick Up the Pace on Patient Centricity

> READ ARTICLE

Four Pillars to Achieve Patient Centricity

> READ ARTICLE

E-book: Inviting Patients to the Center of Drug Development
Learn how life sciences companies can embrace patient centricity and start reaping its benefits with ZS’s four-pillar patient centricity framework.

Article: Four Pillars to Achieve Patient Centricity
Read our byline article in ACT to learn four pillars of patient centricity that help life sciences companies adapt to ever-evolving patient needs and to improve clinical trial outcomes.

Video: Four Pillars to Achieve Patient Centricity
Watch this video to learn the challenges life sciences companies encounter while taking steps towards patient centricity and a four- pillar strategy to accomplish patient centricity.

Article: Pick Up the Pace on Patient Centricity
Read this article to learn how a patient-centered approach can alter clinical trials and the four pillars you need to incorporate today.

Blog: How to Develop a Patient-Centric R&D Process
Learn the steps life sciences can take to start their journey towards patient centricity.

Blog: How Biopharma Companies Are Working to Uncover and Meet Patient Needs Learn how life sciences companies can collaborate with patients to uncover their needs.

Blog: How Technology and Analytics Are Helping Big Pharma Improve Patient Engagement in R&D
Learn how progressive life sciences companies are leveraging technology to connect with patients in new ways.

Blog: How Pharma Companies Are Engaging Patients as R&D Partners
Discover how progressive life sciences companies have involved patients beyond trials.

Pick Up the Pace on Patient Centricity

> READ ARTICLE

Four Pillars to Achieve Patient Centricity

> READ ARTICLE